🇺🇸 FDA
Patent

US 8841282

Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels

granted A61PA61P1/04A61P19/02

Quick answer

US patent 8841282 (Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/04, A61P19/02, A61P25/00, A61P25/04